← Evidence map

ArticleNature reviews. Endocrinology2017

Therapy: SGLT inhibition in T1DM - definite benefit with manageable risk.

Ele Ferrannini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29076505